An insight into the antifungal pipeline: Selected new molecules and beyond

Luis Ostrosky-Zeichner, Arturo Casadevall, John N. Galgiani, Frank C. Odds, John H. Rex

Research output: Contribution to journalReview articlepeer-review

269 Scopus citations


Invasive fungal infections are increasing in incidence and are associated with substantial mortality. Improved diagnostics and the availability of new antifungals have revolutionized the field of medical mycology in the past decades. This Review focuses on recent developments in the antifungal pipeline, concentrating on promising candidates such as new azoles, polyenes and echinocandins, as well as agents such as nikkomycin Z and the sordarins. Developments in vaccines and antibody-based immunotherapy are also discussed. Few therapeutic products are currently in active development, and progression of therapeutic agents with fungus-specific mechanisms of action is of key importance.

Original languageEnglish (US)
Pages (from-to)719-727
Number of pages9
JournalNature Reviews Drug Discovery
Issue number9
StatePublished - Sep 2010
Externally publishedYes

ASJC Scopus subject areas

  • Pharmacology
  • Drug Discovery


Dive into the research topics of 'An insight into the antifungal pipeline: Selected new molecules and beyond'. Together they form a unique fingerprint.

Cite this